{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:24:02Z","timestamp":1649172242136},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00104-021-01521-7","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T14:29:56Z","timestamp":1634653796000},"page":"266-273","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperatives Management von Thrombozytenaggregation und Antikoagulation bei geriatrischen Patienten"],"prefix":"10.1007","volume":"93","author":[{"given":"Romana","family":"Lenzen-Gro\u00dfimlinghaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"1521_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3238\/arztebl.2018.0776","volume":"115","author":"E Altiok","year":"2018","unstructured":"Altiok\u00a0E, Marx\u00a0N (2018) Oral anticoagulation\u2014update on anticoagulation with vitamin K antagonists and non\u2013vitamin K\u2013dependent oral anticoagulants. Dtsch Arztebl Int 115:776\u2013783. https:\/\/doi.org\/10.3238\/arztebl.2018.0776","journal-title":"Dtsch Arztebl Int"},{"key":"1521_CR2","unstructured":"Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses \u00fcber eine \u00c4nderung der Arzneimittel-Richtlinie (AM-RL): Anlage XII \u2013 Nutzenbewertung von Arzneimitteln mit neuen Wirkstoffen nach \u00a7 35a des F\u00fcnften Buches Sozialgesetzbuch (SGB V) Andexanet alfa Vom 20. Februar 2020. https:\/\/www.bundesanzeiger.de\/pub\/publication\/dsDh7FREyeRPo2aaNZt\/content\/dsDh7FREyeRPo2aaNZt\/BAnz%20AT%2027.03.2020%20B4.pdf?inline (Letzter Zugriff 22. 6. 2021)"},{"key":"1521_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901778","author":"DL Bhatt","year":"2019","unstructured":"Bhatt\u00a0DL, Pollack\u00a0CV et al (2019) Antibody-based ticagrelor reversal agent in healthy volunteers. N\u00a0Eng J Med. https:\/\/doi.org\/10.1056\/NEJMoa1901778","journal-title":"N Eng J Med"},{"key":"1521_CR4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814051","author":"SJ Connolly","year":"2019","unstructured":"Connolly\u00a0SJ (2019) Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors. N\u00a0Eng J Med. https:\/\/doi.org\/10.1056\/NEJMoa1814051","journal-title":"N Eng J Med"},{"key":"1521_CR5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s40265-020-01345-5","volume":"80","author":"RM Crawley","year":"2020","unstructured":"Crawley\u00a0RM, Anderson\u00a0RL (2020) Prevention and treatment of bleeding with direct oral anticoagulants. Drugs 80:1293\u20131308","journal-title":"Drugs"},{"key":"1521_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1503\/cmaj.050011","volume":"173","author":"PJ Devereaux","year":"2005","unstructured":"Devereaux\u00a0PJ, Goldman\u00a0L, Cook\u00a0DJ et\u00a0al (2005) Perioperative cardiac events in patients undergoing noncardiac surgery: a\u00a0review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173:627\u2013634","journal-title":"CMAJ"},{"key":"1521_CR7","doi-asserted-by":"publisher","first-page":"e326S","DOI":"10.1378\/chest.11-2298","volume":"141","author":"JD Douketis","year":"2012","unstructured":"Douketis\u00a0JD, Spyropoulos\u00a0AC, Spencer\u00a0FA et al (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice guidelines. Chest 141:e326S\u2013e350S","journal-title":"Chest"},{"issue":"11","key":"1521_CR8","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","volume":"179","author":"D Douketis","year":"2019","unstructured":"Douketis D, Spyropoulos AC et al (2019) Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 179(11):1469\u20131478. https:\/\/doi.org\/10.1001\/jamainternmed.2019.2431","journal-title":"JAMA Intern Med"},{"key":"1521_CR9","unstructured":"Fachinformation Certoparin Aspen M\u00fcnchen, April 2018"},{"key":"1521_CR10","unstructured":"Fachinformation Dalteparin, Pfizer, Juni 2016"},{"key":"1521_CR11","unstructured":"Fachinformation Enoxaparin, Sanofi, April 2018"},{"key":"1521_CR12","unstructured":"Fachinformation Tinzaparin, LEO-Pharma, September 2016"},{"key":"1521_CR13","unstructured":"Fachinformation Apixaban 5\u202fmg, 2,5\u202fmg Filmtabletten Bristol-Myers Squibb, Pfizer Februar 2019"},{"key":"1521_CR14","unstructured":"Fachinformation Dabigatran 150\u202fmg, 110\u202fmg Boehringer Ingelheim, Juni 2018"},{"key":"1521_CR15","unstructured":"Fachinformation Edoxaban 60\u202fmg, 30\u202fmg Filmtabletten Daiichi-Sankyo, August 2018"},{"key":"1521_CR16","unstructured":"Fachinformation Rivaroxaban 20\u202fmg, 15\u202fmg Bayer, August 2018"},{"key":"1521_CR17","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00113-010-1881-x","volume":"113","author":"W Gogarten","year":"2010","unstructured":"Gogarten\u00a0W, Hoffmann\u00a0K et\u00a0al (2010) Empfehlungen f\u00fcr die Anwendung konventioneller und neuer Antithrombotika aus an\u00e4sthesiologischer Sicht. Unfallchirurg 113:908\u2013914. https:\/\/doi.org\/10.1007\/s00113-010-1881-x","journal-title":"Unfallchirurg"},{"key":"1521_CR18","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3238\/arztebl.2018.0287","volume":"115","author":"GH Heine","year":"2018","unstructured":"Heine\u00a0GH, Brandenburg\u00a0V et al (2018) Oral anticoagulation in chronic kidney disease and atrial fibrillation\u2014the use of non-vitamin K\u2011dependent anticoagulants and vitamin K antagonists. Dtsch Arztebl Int 115:287\u2013294. https:\/\/doi.org\/10.3238\/arztebl.2018.0287","journal-title":"Dtsch Arztebl Int"},{"issue":"5","key":"1521_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2020","unstructured":"Hindricks\u00a0G, Poppara\u00a0T, Dagres\u00a0N et al (2020) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart\u00a0J 42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"1521_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00108-017-0243-y","volume":"58","author":"B Kemkes-Matthes","year":"2017","unstructured":"Kemkes-Matthes\u00a0B (2017) Antikoagulation \u2013 direkte orale Antikoagulanzien. Internist 58:585\u2013597. https:\/\/doi.org\/10.1007\/s00108-017-0243-y","journal-title":"Internist"},{"key":"1521_CR21","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"SD Kristensen","year":"2014","unstructured":"Kristensen\u00a0SD, Knuuti\u00a0J, Saraste\u00a0A et al (2014) 2014 ESC\/ESA Guidelines on noncardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart\u00a0J 35:2383\u20132431","journal-title":"Eur Heart J"},{"key":"1521_CR22","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3238\/arztebl.2020.0312","volume":"117","author":"E Lindhoff-Last","year":"2020","unstructured":"Lindhoff-Last\u00a0E, Herrmann\u00a0E, Lindau\u00a0S et al (2020) Severe hemorrhage associated with oral anticoagulants\u2014a\u00a0prospective observational study of the clinical course during treatment with vitamin K antagonists or direct oral anticoagulants. Dtsch Arztebl Int 117:312\u2013319. https:\/\/doi.org\/10.3238\/arztebl.2020.0312","journal-title":"Dtsch Arztebl Int"},{"key":"1521_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11239-009-0412-5","volume":"29","author":"M Makris","year":"2010","unstructured":"Makris\u00a0M, VanVeen\u00a0JJ et\u00a0al (2010) Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient. J\u00a0Thromb Thrombolysis 29:171\u2013181","journal-title":"J Thromb Thrombolysis"},{"key":"1521_CR24","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3238\/arztebl.2017.0473","volume":"114","author":"L Pl\u00fcmer","year":"2017","unstructured":"Pl\u00fcmer\u00a0L, Seiffert\u00a0M et al (2017) Aspirin before elective surgery\u2014stop or continue? A single-center cross-sectional study. Dtsch Arztebl Int 114:473\u2013480. https:\/\/doi.org\/10.3238\/arztebl.2017.0473","journal-title":"Dtsch Arztebl Int"},{"key":"1521_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1056\/NEJMoa1502000","volume":"373","author":"CV Pollack","year":"2015","unstructured":"Pollack\u00a0CV (2015) Idarucizumab for Dabigatran reversal. N\u00a0Engl J Med 373:511\u2013520. https:\/\/doi.org\/10.1056\/NEJMoa1502000","journal-title":"N Engl J Med"},{"key":"1521_CR26","unstructured":"Praxbind, INN-Idarucizumab (europa.eu). https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/praxbind-epar-product-information_de.pdf. Zugegriffen: 22. Juni 2021"},{"key":"1521_CR27","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.jacc.2015.08.002","volume":"66","author":"SJ Rechenmacher","year":"2015","unstructured":"Rechenmacher\u00a0SJ, Fang\u00a0JC (2015) Bridging anticoagulation: primum non nocere. J\u00a0Am Coll Cardiol 66:1392\u20131403","journal-title":"J Am Coll Cardiol"},{"key":"1521_CR28","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1007\/s00108-018-0447-9","volume":"59","author":"SM Schellong","year":"2018","unstructured":"Schellong\u00a0SM, Riess\u00a0H et al (2018) \u00dcberbr\u00fcckende Antikoagulation bei Patienten unter Vitamin-K-Antagonisten. Eine Bestandsaufnahme. Internist 59:744\u2013752. https:\/\/doi.org\/10.1007\/s00108-018-0447-9","journal-title":"Internist"},{"key":"1521_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","volume":"56","author":"RF Storey","year":"2010","unstructured":"Storey\u00a0RF et\u00a0al (2010) Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. Am Coll Cardiol 56:1456\u20131462","journal-title":"Am Coll Cardiol"},{"key":"1521_CR30","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCULATIONAHA.117.028321","volume":"136","author":"J Sundstr\u00f6m","year":"2017","unstructured":"Sundstr\u00f6m\u00a0J, Hedberg\u00a0J, Thuresson\u00a0M et al (2017) Low-dose aspirin discontinuation and risk of cardiovascular events. A Swedish nationwide, population-based cohort study. Circulation 136:1183\u20131192. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.028321","journal-title":"Circulation"},{"key":"1521_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419","author":"M Valgimigli","year":"2017","unstructured":"Valgimigli\u00a0M, Bueno\u00a0H, Byrne\u00a0RA et al (2017) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart\u00a0J. https:\/\/doi.org\/10.1093\/eurheartj\/ehx419","journal-title":"Eur Heart J"},{"key":"1521_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0049-3848(02)00402-4","volume":"108","author":"M Yasaka","year":"2002","unstructured":"Yasaka\u00a0M, Sakata\u00a0T, Minesatsu\u00a0K et\u00a0al (2002) Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhage complication. Thromb Res 108:25\u201330","journal-title":"Thromb Res"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-021-01521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-021-01521-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-021-01521-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T10:13:32Z","timestamp":1646302412000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00104-021-01521-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1521"],"URL":"https:\/\/doi.org\/10.1007\/s00104-021-01521-7","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"22 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"R.\u00a0Lenzen-Gro\u00dfimlinghaus gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}